반응식
[NH2:1][CH:2]1[C:8](=[O:9])[NH:7][C:6]2[CH:10]=[CH:11][CH:12]=[CH:13][C:5]=2[NH:4][C:3]1=[O:14].[F:15][C:16]([F:23])([F:22])[CH2:17][CH2:18][C:19](O)=[O:20]>CN(C)C1C=CN=CC=1.CN(C=O)C>[O:9]=[C:8]1[NH:7][C:6]2[CH:10]=[CH:11][CH:12]=[CH:13][C:5]=2[NH:4][C:3](=[O:14])[CH:2]1[NH:1][C:19](=[O:20])[CH2:18][CH2:17][C:16]([F:23])([F:22])[F:15]참가 물질
실험 절차
Combine 3-amino-1H-1,5-benzodiazepine-2,4-(3H, 5H)-dione (5.60 g, 29.3 mmol), 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimde hydrochloride (6.75 g, 35.2 mmol) and 4(dimethylamino)pyridine (0.183 g, 1.5 mmol) in 100 mL DMF, add 4,4,4-trifluoro butyric acid dropwise at 0-5° C. After addition, stir the reaction mixture at ice-water. After half an hour, warm to RT. After stirring overnight, remove solvent DMF under reduce pressure and suspend the residue in 200 mL of mixed solvent (CHCl3: i-PrOH=3:1). Collect the solid via vacuum filtration to give the title compound (6.87 g, yield 74%): mass spectrum (APCI) (m/e): 316.1 (M+1); 1H NMR (400 MHz, DMSO-d6): δ 10.72 (s, 2H), 8.60 (d, 1H, J=7.2 Hz), 7.24-7.15 (m, 4H), 4.74 (d, 1H, J=7.2 Hz), 2.58 (t, 2H, J=7.2 Hz), 2.39-2.35 (m, 2H).
후처리
- additionAfter addition
- waitAfter half an hour
- customremove solvent DMF
- customCollect the solid
- filtrationvia vacuum filtration
출처 및 근거
- ORD 기록
- ord-de96973e6ca942bba5431d5ecdb42ab3
- 출처 데이터셋
- uspto-grants-2008_06
- 특허 번호
- US07384934B2
연결된 노트
불러오는 중…